30 closest matches · ranked by relevance
PreDiabetes
Primary: Change in Glycosylated Hemoglobin A1c (HbA1c) at 6 Months — -0.07; -0.06 Percentage — p=0.7436
COPD
Primary: Change in Health-related Quality of Life at 6 Months — -1.78; -0.52 units on a scale — p=0.467
Psychotic Disorder
Primary: Intervention Engagement — 8 Participants
Hypertension · Arthritis · Coronary Artery Disease
Primary: Health Related Quality of Life (HRQOL) — 32.73; 32.74; 34.49; 33.89 score on a scale
Depression in Old Age
Primary: Intervention Feasibility — 28 Participants
Cardiovascular Disease
Primary: Feasibility of Enrollment — 25; 7; 13; 0 Participants
Sickle Cell Disease · Chronic Kidney Diseases · Systemic Lupus Erythematosus
Primary: Change in Self-management as Measured by the Partners in Health Scale — 6.7; 6.5; 6.8; 6.6 score on a scale — p=0.0034
Depression
Primary: Change in Functional Status-Mental Health (MCS) Over 12 Month Period — 32.71; 33.72; 34.77; 36.58 units on a scale — p=<0.05
Peer Influence · Medication Adherence · Self Care
Primary: Medication Adherence Status — 29; 39; 18; 8 Participants
Peer Support and Chronic Disease · Obesity · Type II Diabetes
Primary: Feasibility as Measured by Retention — 62 Participants
Wellness Programs · Hospitalization · Emergency Room
Primary: Number of Hospitalizations, Emergency Department Visits, and Urgent Care Visits — 59; 53; 43; 51 Participants
Depression
Primary: Patient Health Questionnaire-9 — 6.66; 7.33; 7.89; 7.84 score on a scale — p=<0.0001
Irritable Bowel Syndrome (IBS) · Functional Abdominal Pain · Fibromyalgia
Primary: Adherence to Physician Recommended CAM Therapies — 1.34; 2.23 Visits to CAM therapists per week
COPD · Self-management Behaviors
Primary: COPD Assessment Test (CAT) — 22.0; 21.9; 21.5; 22.7 score on a scale
Cancer Survivor
Primary: Feasibility as Measured by Study Enrollment Rates, Retention Rates, Adherence to the Intervention, and Reasons for Study Drop Out. — 20; 11; 8; 0 Participants
Type 2 Diabetes
Primary: Hemoglobin A1c — 7.004; 6.24; 6.47 percentage of hemoglobin
Obesity
Primary: Weight Change (kg) — 1.2; 2.5 kilograms
Diabetes Insipidus
Primary: Change in Glycemic Control — 8.92; 9.12; 8.26; 8.16 % glycolated hemoglobin
Suicide
Primary: Questionnaire About the Process of Recovery (QPR) Change — 48.3; 50.1 score on a scale — p=.05
Physical Activity · Peer Leaders · Diet Quality
Primary: Change in Cardiovascular Endurance — 20 yards — p=<0.05
Chronic Kidney Disease
Primary: Slope of Change in Kidney Disease Quality of Life-36 Score — 2.21; 4.13; -0.50; 3.00 Scores on a scale / Months — p=<0.05
Diabetes Mellitus, Type 2
Primary: Percent of Participants With Adherence to the PDTA — 98; 98; 98 percentage of participants
Diabetes
Primary: Percent Glycosylated Hemoglobin — 8.38; 8.39 Percent glycosylated hemoglobin
Type 1 Diabetes
Primary: Glycemic Control (HbA1c) — 9.1; 6.5; 8.5; 9.2 Percentage of HbA1c
Obesity
Primary: Clinically Significant Weight Loss — 39; 40 Participants — p=>0.05
Type 2 Diabetes Mellitus
Primary: Change in Glucose Control (Stage 1: Usual Care v. Peer Mentoring) — -0.1978; -0.5246 percent — p=0.0611
Depression
Primary: Depression With PHQ-9 — 7.7 units on a scale
Hypertension
Primary: Change in Systolic Blood Pressure — -3.48; -5.45 mm Hg — p=0.2417
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
Chronic Pain
Primary: Brief Pain Inventory (BPI) (Overall Pain Assessment) — 5.6; 5.6 units on a scale — p=0.981